TC
MRNA icon

TwinBeech Capital’s Moderna MRNA Stock Holding History

TwinBeech Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-34,668
Closed -$1.76M – 572
2026
Q1 		$1.76M Sell
34,668
-246,546
-88% -$11.5M 0.18% 165
2025
Q4 		$8.29M Buy
281,214
+66,354
+31% +$1.8M 0.59% 46
2025
Q3 		$5.55M Buy
214,860
+161,915
+306% +$4.52M 0.22% 128
2025
Q2 		$1.46M Buy
+52,945
New +$1.39M 0.03% 363
2024
Q3 		– Sell
-246,518
Closed -$29.3M – 808
2024
Q2 		$29.3M Buy
+246,518
New +$31.2M 0.58% 56
2021
Q1 		– Sell
-13,672
Closed -$1.43M – 586
2020
Q4 		$1.43M Buy
+13,672
New +$1.38M 0.23% 134

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

TwinBeech Capital's MRNA Position: Q2 2026 in Review

TwinBeech Capital sold out of Moderna (MRNA) in Q2 2026, closing a stake of 34,668 shares — an estimated $1.76M sold.

TwinBeech Capital first reported a position in MRNA in Q4 2020 and held it in 6 quarters. The position peaked at $29.3M in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • TwinBeech Capital reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • TwinBeech Capital sold 34,668 Moderna shares in Q2 2026, an estimated $1.76M.
  • TwinBeech Capital first reported a position in Moderna in Q4 2020 and held it in 6 quarters.
  • TwinBeech Capital's Moderna position peaked at $29.3M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.